Recent insider trading activity from Litten Jason, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | GENELUX Corp | $GNLX | Litten Jason | Chief Medical Officer | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 38,051,771 | 9999.99% | 0.72% |